Abstract
A review of the literature together with personal results show that both growth hormone (GH) and estrogen treatments improve bone mineral density (BMD) in patients with Turner syndrome. Insofar as GH treatment alone appears to normalize BMD in girls with Turner syndrome it is suggested that substitutive estrogen treatment could be delayed in order to guarantee optimal result for their statural growth, without affecting the quality of their bone mineralization.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
